Acutus Medical (AFIB) Competitors $0.06 0.00 (-5.00%) (As of 02:35 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsTrends AFIB vs. CUTR, BTCY, STSS, AEMD, CTCX, CHEK, POAI, QNRX, SINT, and BBLGShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Cutera (CUTR), Biotricity (BTCY), Sharps Technology (STSS), Aethlon Medical (AEMD), Carmell (CTCX), Check-Cap (CHEK), Predictive Oncology (POAI), Quoin Pharmaceuticals (QNRX), Sintx Technologies (SINT), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Cutera Biotricity Sharps Technology Aethlon Medical Carmell Check-Cap Predictive Oncology Quoin Pharmaceuticals Sintx Technologies Bone Biologics Cutera (NASDAQ:CUTR) and Acutus Medical (NASDAQ:AFIB) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, community ranking, risk and media sentiment. Is CUTR or AFIB more profitable? Cutera has a net margin of -84.86% compared to Acutus Medical's net margin of -272.74%. Cutera's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Cutera-84.86% N/A -45.07% Acutus Medical -272.74%-311.64%-11.57% Does the media favor CUTR or AFIB? In the previous week, Acutus Medical had 3 more articles in the media than Cutera. MarketBeat recorded 3 mentions for Acutus Medical and 0 mentions for Cutera. Acutus Medical's average media sentiment score of 0.28 beat Cutera's score of 0.00 indicating that Acutus Medical is being referred to more favorably in the news media. Company Overall Sentiment Cutera Neutral Acutus Medical Neutral Which has better valuation and earnings, CUTR or AFIB? Acutus Medical has lower revenue, but higher earnings than Cutera. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCutera$212.37M0.03-$162.83M-$6.58-0.05Acutus Medical$7.16M0.24-$81.66MN/AN/A Do institutionals & insiders hold more shares of CUTR or AFIB? 90.7% of Cutera shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 0.4% of Cutera shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts prefer CUTR or AFIB? Cutera currently has a consensus target price of $3.00, suggesting a potential upside of 858.16%. Given Cutera's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cutera is more favorable than Acutus Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cutera 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Acutus Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor CUTR or AFIB? Cutera received 324 more outperform votes than Acutus Medical when rated by MarketBeat users. Likewise, 64.62% of users gave Cutera an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote. CompanyUnderperformOutperformCuteraOutperform Votes33664.62% Underperform Votes18435.38% Acutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% SummaryCutera beats Acutus Medical on 9 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.70M$4.47B$5.10B$8.84BDividend YieldN/A36.79%5.04%4.07%P/E RatioN/A14.4395.6214.26Price / Sales0.2443.911,217.1987.73Price / CashN/A52.2739.5936.27Price / Book-0.165.816.946.36Net Income-$81.66M$13.76M$118.89M$225.56M7 Day PerformanceN/A-0.25%-1.33%-0.10%1 Month PerformanceN/A1.34%-3.17%2.02%1 Year PerformanceN/A51.56%32.49%27.87% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.06-5.0%N/A-82.5%$1.70M$7.16M0.00340Gap DownCUTRCutera1.1178 of 5 stars$0.31+3.6%$3.00+858.2%-86.7%$6.32M$212.37M-0.05430Analyst ForecastGap DownBTCYBiotricityN/A$0.28-11.9%N/A-66.9%$6.27M$12.06M-0.2340Analyst ForecastAnalyst RevisionNews CoverageSTSSSharps Technology0.7782 of 5 stars$3.43+6.2%N/AN/A$6.17MN/A-0.383Gap DownAEMDAethlon Medical2.8661 of 5 stars$0.38-1.9%$7.00+1,729.6%-77.2%$5.34M$570,000.00-0.1410CTCXCarmellN/A$0.24-1.0%N/A-90.9%$5.09MN/A0.0014CHEKCheck-Cap0.5192 of 5 stars$0.80+5.0%N/A-76.9%$4.68MN/A-0.2780Upcoming EarningsNews CoverageGap UpPOAIPredictive Oncology2.1484 of 5 stars$0.67+2.4%$3.00+348.9%-78.2%$4.46M$1.78M0.0030Analyst RevisionGap UpQNRXQuoin Pharmaceuticals2.236 of 5 stars$0.63+0.7%$4.00+534.9%-84.9%$3.18MN/A-0.164Negative NewsGap DownSINTSintx Technologies0.3576 of 5 stars$4.13+11.0%N/A-95.6%$3.10M$2.63M-0.0843Gap UpBBLGBone Biologics0.1297 of 5 stars$1.24-1.6%N/A-73.3%$3.05MN/A0.002Negative News Related Companies and Tools Related Companies CUTR Competitors BTCY Competitors STSS Competitors AEMD Competitors CTCX Competitors CHEK Competitors POAI Competitors QNRX Competitors SINT Competitors BBLG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AFIB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
